53
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study

&
Pages 631-639 | Published online: 17 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ruiying Kang, Yan He, Yuxiang Yan, Zhiwu Li, Yeqing Wu, Xiaojuan Guo, Zhigang Liang & Jun Jiang. (2015) Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial. Neuropsychiatric Disease and Treatment 11, pages 1307-1311.
Read now

Articles from other publishers (8)

RenukaL Kadam, SmitaDipak Sontakke, Prashant Tiple, VijayM Motghare, ChaitaliS Bajait & MrunaliniV Kalikar. (2020) Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study. Indian Journal of Pharmacology 52:2, pages 79.
Crossref
Benjamin N. Greenwood. (2019) The role of dopamine in overcoming aversion with exercise. Brain Research 1713, pages 102-108.
Crossref
Rebecca Robillard, Joanne S. Carpenter, Kristy-Lee Feilds, Daniel F. Hermens, Django White, Sharon L. Naismith, Delwyn Bartlett, Bradley Whitwell, James Southan, Elizabeth M. Scott & Ian B. Hickie. (2018) Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study. Frontiers in Psychiatry 9.
Crossref
Gregory M. Brown, Roger S. McIntyre, Joshua Rosenblat & Rüdiger Hardeland. (2018) Depressive disorders: Processes leading to neurogeneration and potential novel treatments. Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, pages 189-204.
Crossref
Jin-Yi Hyeon, Eun-Young Choi, So-Hui Choe, Hae Ryoun Park, Jeom-Il Choi, In Soon Choi & Sung-Jo Kim. (2017) Agomelatine, a MT1/MT2 melatonergic receptor agonist with serotonin 5-HT2C receptor antagonistic properties, suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages. Archives of Oral Biology 82, pages 11-18.
Crossref
Venkataramanujam Srinivasan, Domenico de Berardis, Michele Fornaro, Francisco López-Muñoz, Timo Partonen & Rahimah Zakaria. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy 117 127 .
Venkataramanujam Srinivasan, Domenico de Berardis, Michele Fornaro, Francisco Lopez-Muñoz, Rahimah Zakaria, Mohd Jamil Yaacob & Zahiruddin Othman. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy 219 228 .
F İlkaya, M Yüce, AE Ağrı, H Güzel, H Balcı, F Uçar, Z Babadağı, M Müjdeci & E Mutlu. (2014) The combination of agomelatine and ritanserin exerts a synergistic interaction in passive avoidance task. Human & Experimental Toxicology 34:8, pages 787-795.
Crossref